{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:02:46Z","timestamp":1790298166315,"version":"4.1.0"},"reference-count":25,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chengdu Medical Research Project","award":["2022363"],"award-info":[{"award-number":["2022363"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"abstract":"<jats:p>There are no international or Chinese guidelines for the management of dry eye disease that develops after corneal refractive surgery. Sodium hyaluronate is the first-line therapy for dry eye diseases but is not sufficient to treat severe conditions. This study aimed to compare three-month outcomes following treatment of dry eyes after corneal refractive surgery with 3% diquafosol against those with 0.1% sodium hyaluronate. In a retrospective study, 118 patients were treated with 3% diquafosol sodium six times\/day (DQS cohort, n=118 eyes) and 184 patients were treated with 0.1% sodium hyaluronate four times\/day (SH cohort, n=184 eyes) for three months. Before treatments (BT), the ocular surface damage score was between 5 and 9 per eye, the ocular surface disease index was between 64 and 70% per eye, and the subjective symptom questionnaire score was between 13 and 19 per eye. Wet length of Schirmer's I strip test, ocular surface damage score, ocular surface disease index, and subjective symptom questionnaire scores improved in both cohorts after 3 months of treatments (AT) compared to BT conditions (P&lt;0.01 for all comparisons). However, improvement was greater in the DQS cohort than in the SH cohort in the AT condition (P&lt;0.01 for all comparisons). Blurred vision, ocular discomfort, and foreign body sensations were observed in a few cases. Dry eye disease is a common complication after corneal refractive surgery, and there is a lack of international guidelines addressing its management. Three percent diquafosol showed superior improvement of dry eye parameters post-refractive surgery than 0.1% sodium hyaluronate.<\/jats:p>","DOI":"10.1590\/1414-431x2025e14754","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T15:04:32Z","timestamp":1759763072000},"source":"Crossref","is-referenced-by-count":1,"title":["Comparison of two treatments for dry eye disease after corneal refractive surgery"],"prefix":"10.1590","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5144-1814","authenticated-orcid":false,"given":"Yiping","family":"Ma","sequence":"first","affiliation":[{"name":"Chengdu Aidi Eye Hospital,  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3918-2529","authenticated-orcid":false,"given":"Yukun","family":"Yang","sequence":"additional","affiliation":[{"name":"Chengdu Aidi Eye Hospital,  China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"issue":"2","key":"ref1","first-page":"81","article-title":"The rapid development and changes of corneal refractive surgery in China [in Chinese]","volume":"56","author":"Wang Y","year":"2020","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4274\/tjo.galenos.2019.45538","article-title":"Dry eye disease after cataract surgery: Study of its determinants and risk factors","volume":"50","author":"Garg P","year":"2020","journal-title":"Turk J Ophthalmol"},{"issue":"14","key":"ref3","doi-asserted-by":"crossref","first-page":"DES109","DOI":"10.1167\/iovs.17-23538","article-title":"Dry eye after LASIK","volume":"59","author":"Toda I","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10185","key":"ref4","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(18)33209-4","article-title":"Refractive surgery","volume":"393","author":"Kim TI","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jamaophthalmol.2019.4815","article-title":"Characteristics and risk factors associated with diagnosed and undiagnosed symptomatic dry eye using a smartphone application","volume":"138","author":"Inomata T","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2737968","DOI":"10.1155\/2019\/2737968","article-title":"Preoperative management of MGD alleviates the aggravation of MGD and dry eye induced by cataract surgery: a prospective, randomized clinical trial","volume":"2019","author":"Song P","year":"2019","journal-title":"Biomed Res Int"},{"issue":"7","key":"ref7","first-page":"1122","article-title":"Changes in ocular surface status and dry eye symptoms following femtosecond laser-assisted cataract surgery","volume":"12","author":"Ju RH","year":"2019","journal-title":"Int J Ophthalmol"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s10792-020-01294-8","article-title":"A study of dry eye after cataract surgery in MGD patients","volume":"40","author":"Qiu JJ","year":"2020","journal-title":"Int Ophthalmol"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/ICO.0000000000001572","article-title":"Perioperative ocular parameters associated with persistent dry eye symptoms after cataract surgery","volume":"37","author":"Choi YJ","year":"2018","journal-title":"Cornea"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1515\/folmed-2017-0007","article-title":"Emulsion of chloramphenicol: an overwhelming approach for ocular delivery","volume":"59","author":"Ashara KC","year":"2017","journal-title":"Folia Med (Plovdiv)"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"e052488","DOI":"10.1136\/bmjopen-2021-052488","article-title":"Clinical efficacy of diquafosol sodium 3% versus hyaluronic acid 0.1% in patients with dry eye disease after cataract surgery: A protocol for a single-centre, randomised controlled trial","volume":"12","author":"Miura M","year":"2022","journal-title":"BMJ Open"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10384-020-00798-1","article-title":"Heterogeneity of eye drop use among symptomatic dry eye individuals in Japan: large-scale crowdsourced research using Dry Eye Rhythm application","volume":"65","author":"Eguchi A","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1160499","DOI":"10.3389\/fmed.2023.1160499","article-title":"Combination therapy with 3% diquafosol tetrasodium ophthalmic solution and sodium hyaluronate: an effective therapy for patients with dry eye after femtosecond laser-assisted in situ keratomileusis","author":"Wang T","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2147\/OPTH.S69486","article-title":"Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes","volume":"9","author":"Koh S","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"ref15","series-title":"StatPearls [Internet]","volume-title":"Dry Eye Syndrome","author":"Golden MI","year":"2025"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.18240\/ijo.2021.06.07","article-title":"Reliability of Chinese web-based ocular surface disease index questionnaire in dry eye patients: a randomized, crossover study","volume":"14","author":"Zhang XM","year":"2021","journal-title":"Int J Ophthalmol"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/diseases12080192","article-title":"Effectiveness of an acupuncture steam-warming eye mask on dry eye disease in visual display terminal users: a prospective randomized controlled trial","volume":"12","author":"Lee CY","year":"2024","journal-title":"Diseases"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.oooo.2022.05.002","article-title":"Diagnostic efficacy of physical examination, preoperative ultrasound, and\/or computed tomography in detecting lymph node metastasis: a single-center retrospective analysis of patients with squamous cell carcinoma of the head and neck","volume":"134","author":"Zhang Y","year":"2022","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"1 Suppl","key":"ref19","first-page":"173","article-title":"The study of chloramphenicol for ophthalmic formulation","volume":"7","author":"Ashara KC","year":"2018","journal-title":"IJSRR"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/ICO.0000000000000136","article-title":"Effect of diquafosol tetrasodium eye drop for persistent dry eye after laser in situ keratomileusis","volume":"33","author":"Mori Y","year":"2014","journal-title":"Cornea"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2147\/OPTH.S148167","article-title":"Effect of topical 3% diquafosol sodium on eyes with dry eye disease and meibomian gland dysfunction","volume":"11","author":"Amano S","year":"2017","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1038\/s41598-021-88589-7","article-title":"A randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery","volume":"11","author":"Kim S","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.1038\/s41598-021-86433-6","article-title":"Diquafosol tetrasodium elicits total cholesterol release from rabbit meibomian gland cells via P2Y2 purinergic receptor signalling","volume":"11","author":"Endo KI","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn JS","year":"2017","journal-title":"Ocul Surf"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/bjophthalmol-2012-302668","article-title":"Topical diquafosol for patients with obstructive meibomian gland dysfunction","volume":"97","author":"Arita R","year":"2013","journal-title":"Br J Ophthalmol"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0100-879X2025000100669&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T15:04:36Z","timestamp":1759763076000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2025000100669&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":25,"alternative-id":["S0100-879X2025000100669"],"URL":"https:\/\/doi.org\/10.1590\/1414-431x2025e14754","relation":{},"ISSN":["1414-431X","0100-879X"],"issn-type":[{"value":"1414-431X","type":"electronic"},{"value":"0100-879X","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e14754"}}